1,004 material Form 8-K filings that 784 companies we cover made with the SEC in August 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Otis Worldwide entered a new $1,500 million unsecured revolving credit agreement maturing August 8, 2030, and terminated its existing facility, which was scheduled to expire March 10, 2028, with no early termination penalties. The new facility can be increased by up to $500 million and is for general corporate purposes, with borrowing costs tied to Otis's public debt rating. For shareholders, this is a routine refinancing that extends the company's borrowing runway, though the filing does not report any change in the company's financial results.
New unsecured revolving credit facility of $1,500 million, maturing August 8, 2030
Existing credit agreement terminated on August 8, 2025, which was due to expire March 10, 2028
Initial margin of 1.125% over term SOFR, EURIBO and daily simple ESTR; 0.125% over base rate
Facility includes a maximum consolidated leverage ratio covenant and can be increased by up to $500 million
Kilroy Realty and its operating partnership completed an underwritten public offering of $400 million of 5.875% senior notes maturing October 15, 2035. The company also amended its at-the-market equity sales agreement, with up to $500 million of common stock still available under the program. The filing describes new debt and potential future share sales, but reports no effect on earnings or results.
Operating partnership issued $400 million aggregate principal of 5.875% senior notes, guaranteed by Kilroy Realty Corporation, completed August 8, 2025
Interest payable April 15 and October 15, starting April 15, 2026; maturity October 15, 2035
Up to $500 million of common stock remains available under the at-the-market program, with no shares sold under the prior registration
Notes are senior unsecured and effectively subordinated to mortgage and other secured debt and subsidiary liabilities
Coinbase completed a private offering of $1.5 billion of 0% convertible senior notes due 2029 and $1.5 billion due 2032, including the full exercise of initial purchasers' options for an additional $200.0 million of each series. Holders can convert into cash, Class A common stock, or a combination, at the company's election, so conversions could affect existing shareholders' ownership if the company settles in shares.
$1.5 billion of 0% convertible senior notes due October 1, 2029, with an initial conversion price of about $454.44 per share
$1.5 billion of 0% convertible senior notes due October 1, 2032, with an initial conversion price of about $394.84 per share
Conversion prices carry premiums of about 52.5% (2029 notes) and 32.5% (2032 notes) to the $297.99 closing price on August 5, 2025
The notes are senior unsecured obligations; U.S. Bank Trust Company, National Association is the trustee
John B. Sanfilippo & Son said it eliminated the Vice President, General Counsel position, and Gina Lakatos left the company on August 5, 2025 to pursue other opportunities. The filing thanks Lakatos for her contributions to the company's legal function and does not name a successor or describe any financial effect.
Position eliminated: Vice President, General Counsel, announced August 5, 2025
Gina Lakatos left the company on August 5, 2025 to pursue other opportunities
Filing does not name a replacement or state any financial impact
Report dated August 8, 2025, signed by CFO Frank S. Pellegrino
Lithia Motors entered into a Sixth Amendment to its Fourth Amended and Restated Loan Agreement with U.S. Bank National Association as administrative agent on August 6, 2025. The amendment raises the total financing commitment from $6.0 billion to $6.5 billion, with an option to expand to $7.0 billion subject to lender approval.
Total financing commitment rises from $6.0 billion to $6.5 billion, expandable to $7.0 billion with lender approval
Initial allocations: New Vehicle Floorplan $3.0 billion, Revolver $2.5 billion, Used Vehicle Floorplan $900 million, Service Loaner Floorplan Facility $100 million
Financing Operations interest expense is removed from the fixed charge coverage ratio
American Healthcare REIT, Inc. entered an ATM Equity Offering Sales Agreement on August 8, 2025, allowing it to sell up to $1 billion of common stock through a group of sales agents, replacing its prior at-the-market program. Shares may be sold at times the company chooses, and the company says net proceeds will go to its Operating Partnership for general corporate purposes, which may include repaying debt. Sales could dilute existing shareholders, but the filing does not say whether or when any shares will be sold.
Program covers up to $1 billion aggregate gross sales price of common stock, $0.01 par value
Agents may earn commissions up to 2.0% of gross sales price of shares sold
Prior at-the-market program, dated November 18, 2024, was terminated with no shares left unsold
Shares offered under a prospectus supplement dated August 8, 2025 and a shelf registration on Form S-3
Ball Corporation entered into an underwriting agreement on August 7, 2025 for a $750 million offering of 5.500% Senior Notes due 2033, with closing expected August 14, 2025. The company plans to use net proceeds for general corporate purposes, including repaying outstanding revolving credit facility borrowings, which adds new debt but refinances existing borrowings without reducing commitments.
Offering size: $750 million aggregate principal amount of 5.500% Senior Notes due 2033
Underwriter: BofA Securities, Inc., as representative of the underwriters
Expected closing date: August 14, 2025, subject to customary conditions
Proceeds to be used for general corporate purposes, including repaying U.S. dollar and multi-currency revolving credit borrowings without reducing commitments
Millrose Properties completed the sale of $1.25 billion of 6.375% senior notes maturing August 1, 2030, to qualified institutional and certain non-U.S. buyers under Rule 144A and Regulation S. The notes are senior unsecured and guaranteed by subsidiary Millrose Properties SPE LLC, adding a large layer of new debt to the company's balance sheet.
Notes: $1.25 billion aggregate principal, 6.375% annual interest, paid semi-annually from February 15, 2026
Maturity August 1, 2030; company may redeem from August 1, 2027, with make-whole premium before that date
Indenture with Citibank, N.A. as trustee limits liens, certain sale-leasebacks and mergers; holders can require repurchase at 101% on a change of control
Carnival Corporation entered compensation protection and restrictive covenant agreements on August 6, 2025, with CEO Josh Weinstein, CFO David Bernstein, Chief Human Resources Officer Bettina Deynes and General Counsel Enrique Miguez. The agreements set severance terms if an officer is terminated without cause, through position elimination, certain reassignments or pay cuts, or by mutual agreement, and include non-compete and non-solicitation periods. The filing is routine governance disclosure, with no change in leadership and no dollar severance amounts stated.
Agreements dated August 6, 2025, cover CEO Josh Weinstein, CFO David Bernstein, CHRO Bettina Deynes and General Counsel Enrique Miguez.
CEO severance: two times annualized base salary plus two times target cash bonus, paid over two years, conditional on a release.
Other officers: one times base salary plus 0.5 times target cash bonus, paid over one year.
Non-compete and non-solicitation periods run two years for the CEO and one year for other officers after termination.
Southside Bancshares entered into an underwriting agreement on August 7, 2025, under which it agreed to issue and sell $150 million of 7.00% fixed-to-floating rate subordinated notes due 2035 to underwriters led by Keefe, Bruyette & Woods. The offering is expected to close on or about August 14, 2025, subject to customary closing conditions, and would add $150 million of subordinated debt to the company's obligations.
Notes: $150 million aggregate principal amount of 7.00% fixed-to-floating rate subordinated notes due 2035
Underwriting agreement dated August 7, 2025, among the company, Southside Bank and Keefe, Bruyette & Woods, Inc.
Expected closing on or about August 14, 2025, subject to customary closing conditions
Offering made under an effective Form S-3 registration statement filed April 28, 2023
NeoGenomics director Elizabeth Floegel gave notice on August 5, 2025 that she is resigning from the Board of Directors, effective immediately. The company said her decision did not stem from any disagreement with it on operations, policies or practices.
Director Elizabeth Floegel resigned from the Board of Directors, effective immediately
Resignation notice was provided to the company on August 5, 2025
Company states no disagreement on operations, policies or practices led to the resignation
Filing dated August 8, 2025, signed by EVP, General Counsel and Corporate Secretary Alicia C. Olivo
On August 6, 2025, F&G announced that John Currier will transition from his role as President to a senior advisory role reporting to CEO Chris Blunt. CFO Conor Murphy has also taken on the role of President while keeping his Chief Financial Officer title, and he amended his employment agreement on the same date. The filing shows a change in senior leadership but does not include any financial results.
John Currier is moving from President to a senior advisory role reporting to CEO Chris Blunt, announced August 6, 2025.
Conor Murphy holds the titles of President and Chief Financial Officer.
Amendment No. 1 to Murphy's employment agreement, dated April 1, 2025, was entered into August 6, 2025, and is filed as Exhibit 10.1.
Extra Space Storage LP, a subsidiary of Extra Space Storage Inc. (EXR), completed an underwritten public offering of $800 million in 4.950% senior notes due January 15, 2033. The notes were sold at 99.739% of principal and are fully guaranteed by the parent company and two Massachusetts business trusts. The filing describes new debt that adds to the company's obligations, with restrictive covenants on additional borrowing.
Principal amount of $800 million; public offering price was 99.739% of principal amount
Interest at 4.950% per year, payable January 15 and July 15, beginning January 15, 2026
Maturity date January 15, 2033; redeemable at any time at greater of par or make-whole premium
Indenture includes limits on additional indebtedness and a requirement to maintain a pool of unencumbered assets
American Water Works disclosed the closing of two financings on August 8, 2025: a $900 million offering of 5.700% senior notes due 2055 by its finance subsidiary, and 1,056,338 additional shares of common stock sold to underwriters. The company also entered additional forward sale agreements that could bring in about $147.5 million in net proceeds upon full physical settlement, which would add new shares and dilute existing holders. The filing reports no change to earnings or guidance.
Finance subsidiary AWCC received about $887.2 million in net proceeds from the $900 million 5.700% senior notes due 2055, closed August 8, 2025
Equity underwriters exercised in full a 30-day option on 1,056,338 borrowed shares, with the offering closed August 8, 2025
Forward sale price initially $139.657 per share; settlement at company discretion on or before December 31, 2026
Estimated net proceeds of about $147.5 million if all forward sale agreements settle physically; proceeds intended for general corporate purposes
National HealthCare reported net operating revenues of $374.9 million for the quarter ended June 30, 2025, up 24.7% from $300.7 million a year earlier, driven by a 9.6% rise in same-facility revenues and the August 1, 2024 acquisition of White Oak Management. GAAP net income attributable to NHC fell to $23.7 million from $26.8 million, while adjusted net income rose 64.7% to $25.7 million, so shareholders see higher revenue and adjusted earnings alongside lower GAAP earnings.
Net operating revenues $374.9 million vs $300.7 million, up 24.7%; same-facility net operating revenues up 9.6%
GAAP net income attributable to NHC $23.7 million vs $26.8 million; GAAP diluted EPS $1.52 vs $1.73
Adjusted net income $25.7 million vs $15.6 million, up 64.7%; adjusted diluted EPS $1.65 vs $1.00
Dividends declared of $0.64 per common share for the quarter vs $0.61 a year earlier
Centrus Energy's chief financial officer, Kevin Harrill, resigned on August 7, 2025, to pursue other opportunities, and the board appointed Todd Tinelli to succeed him effective August 11, 2025. Harrill will stay in an advisory role until August 29, 2025, and the company says the departure is not due to any disagreement over operations, policies or practices.
Kevin Harrill resigned as SVP, CFO and Treasurer, effective August 10, 2025, and will advise through August 29, 2025
Todd Tinelli, 45, becomes SVP, CFO and Treasurer effective August 11, 2025; previously CFO and COO of Hartree Partners and Sprague Resources
Tinelli's compensation includes a $425,000 base salary, up to $125,000 relocation benefits, an 80% bonus target, and equity awards of $100,000 stock and $300,000 RSUs
Tinelli must obtain and maintain a DOE "Q" security clearance within 18 months
Triumph Financial, Inc. said it will transfer the listing of its common stock and depositary shares from Nasdaq to the New York Stock Exchange, with NYSE trading expected to begin on or about August 19, 2025. The company will also dual list its common stock on NYSE Texas on or about August 20, 2025. The common stock ticker stays TFIN, but the preferred depositary shares will trade as TFIN PR instead of TFINP.
Nasdaq trading in the common stock and depositary shares is expected to end at the close on or about August 18, 2025.
NYSE trading is expected to begin at market open on or about August 19, 2025, and NYSE Texas trading on or about August 20, 2025.
The preferred depositary shares, each representing a 1/40th interest in a 7.125% Series C preferred stock, change ticker from TFINP to TFIN PR.
The company's CEO, Aaron Graft, said the company believes the NYSE's platform and resources will help unlock greater value for shareholders.
MACOM Technology Solutions said director Susan Ocampo will retire from its Board of Directors effective August 31, 2025, and that her decision is not due to any disagreement with the company on operations, policies or practices. The filing describes her as a director since August 2010 and credits her with contributing to the company's development, but gives no financial results or other operating figures.
Susan Ocampo notified the Board of her retirement decision on August 4, 2025.
Retirement is effective August 31, 2025.
The filing states the decision is not due to any disagreement with MACOM on its operations, policies or practices.
Regal Rexnord said Executive Vice President and President of Automation & Motion Control Kevin Zaba will retire effective December 31, 2025. Kevin Long will become Executive Vice President & President of the segment on August 14, 2025, and Zaba will stay on as an executive vice president through the retirement date to support the handover. The filing gives no financial figures, so the change mainly signals a planned leadership transition in one business unit.
Kevin Zaba informed the company on August 5, 2025, of his intention to retire.
Zaba's retirement is effective December 31, 2025.
Kevin Long becomes Executive Vice President & President, Automation & Motion Control, on August 14, 2025.
Zaba keeps his base salary and benefits, and his equity awards and incentive pay remain under existing plan terms, until he retires.
Koppers reported second quarter 2025 sales of $504.8 million, down from $563.2 million a year earlier, and GAAP diluted EPS of $0.81 versus $1.25. The company cut its 2025 forecast, lowering its sales outlook to $1.9 billion to $2.0 billion from $2.0 billion to $2.2 billion and its adjusted EBITDA outlook to $250 million to $270 million, because it expects continued lower demand. Adjusted EPS rose to $1.48 from $1.36, but the lower sales and guidance cut weigh on the outlook for shareholders.
Q2 2025 net sales were $504.8 million, down 10.4% from $563.2 million; GAAP diluted EPS was $0.81 versus $1.25
Adjusted EPS was $1.48 versus $1.36 a year earlier; adjusted EBITDA was $77.1 million versus $77.5 million
2025 guidance revised: sales of $1.9 billion to $2.0 billion (previously $2.0 billion to $2.2 billion) and adjusted EBITDA of $250 million to $270 million
Adjusted EPS guidance is $4.00 to $4.60; operating cash flow projection of $150 million was maintained
AAM (NYSE: AXL) reported second-quarter 2025 sales of $1.54 billion, down from $1.63 billion a year earlier, while net income rose to $39.3 million from $18.2 million. The filing says the net income increase reflects a $46.3 million gain on its Business Combination Derivative, while Adjusted EBITDA fell to $202.2 million from $208.4 million, and the company raised the low end of several full-year 2025 targets.
Sales were $1.54 billion versus $1.63 billion a year earlier, which the company attributed to lower volume and mix.
Diluted EPS was $0.32 versus $0.15; Adjusted EPS was $0.21 versus $0.19. Adjusted EBITDA margin was 13.2% versus 12.8%.
Full-year 2025 targets: Adjusted EBITDA $695 million to $745 million (previously $665 million to $745 million); sales $5.75 billion to $5.95 billion (previously $5.65 billion to $5.95 billion).
CEO David C. Dauch said shareholders of both companies approved the combination with Dowlais.
Winnebago Industries disclosed that director Jacqueline D. Woods resigned from its Board effective August 4, 2025, under the company's Corporate Governance Policy after a change in her principal employment. The filing does not describe any replacement or other board action, and it reports no financial results.
Jacqueline D. Woods resigned from the Board of Directors effective August 4, 2025.
The Board accepted the resignation on August 4, 2025.
Her resignation followed a change in her principal employment, per the company's Corporate Governance Policy.
Sotera Health reported second-quarter 2025 net revenues up 6.4% to $294 million and Adjusted EBITDA up 9.8% to $151 million, and raised its full-year 2025 outlook for revenue, Adjusted EBITDA and Adjusted EPS. GAAP net income was $8 million, or $0.03 per diluted share, slightly below $9 million a year earlier, and includes a pending settlement of about $34 million related to ethylene oxide claims against Sterigenics.
Q2 2025 net revenues rose 6.4% to $294 million; Adjusted EBITDA rose 9.8% to $151 million
Q2 2025 net income was $8 million, or $0.03 per diluted share, versus $9 million, or $0.03, in Q2 2024
Full-year 2025 Adjusted EPS outlook raised to $0.75 to $0.82 from $0.70 to $0.76
Six-month net loss of $5 million, or $0.02 per diluted share, includes settlements related to ethylene oxide claims
Alpha Metallurgical Resources reported a second-quarter 2025 net loss of $5.0 million, or $0.38 per diluted share, narrowing from a $33.9 million loss in the first quarter but down from a $58.9 million profit a year earlier. The company lowered its 2025 cost of coal sales guidance to $101 to $107 per ton, cut its SG&A guidance, and raised its idle operations expense guidance. It also plans to restart its share repurchase program on an opportunistic basis, having refrained from buybacks for about five quarters.
Q2 2025 net loss of $5.0 million ($0.38 per diluted share) versus a $33.9 million loss in Q1 2025 and net income of $58.9 million in Q2 2024
Adjusted EBITDA of $46.1 million, up from $5.7 million in Q1 2025 and down from $116.0 million in Q2 2024
2025 cost of coal sales guidance lowered to $101 to $107 per ton from $103 to $110; SG&A guidance cut to $48 million to $54 million
Total liquidity of $556.9 million as of June 30, 2025; remaining buyback authorization of approximately $400 million
Under Armour reported first quarter fiscal 2026 results for the quarter ended June 30, 2025. Revenue fell 4% to $1.1 billion, while GAAP net loss narrowed to $3 million from $305 million a year earlier, when results included a litigation reserve. The company expects second quarter revenue to decline 6% to 7% and a GAAP operating loss of up to $10 million, which matters to shareholders because it signals continued sales pressure and uncertainty from tariffs.
Revenue declined 4% to $1.1 billion; North America fell 5% to $670 million and footwear fell 14% to $266 million.
GAAP operating income was $3 million, compared with a loss of $300 million a year earlier; diluted loss per share was $0.01.
Second quarter outlook: revenue down 6% to 7%, GAAP operating loss of $10 million to breakeven, and diluted loss per share of $0.07 to $0.08.
Cash and cash equivalents totaled $911 million, including $400 million in senior notes raised in the quarter, to be used toward $600 million in notes due June 2026.
Sylvamo reported second quarter 2025 net income of $15 million ($0.37 per diluted share), down from $27 million in the first quarter and $83 million a year earlier, with net sales of $794 million and adjusted EBITDA of $82 million. The company said results were in line with its outlook and guided third quarter adjusted EBITDA to $145 million to $165 million, citing lower planned maintenance outage expenses and improved volumes. For shareholders, the quarter was weaker, but the company expects a stronger second half.
Q2 net sales were $794 million, versus $821 million in Q1 2025 and $933 million in Q2 2024.
Net income was $15 million ($0.37 per diluted share), versus $27 million in Q1 2025 and $83 million in Q2 2024.
Third quarter adjusted EBITDA outlook is $145 million to $165 million, with planned maintenance outage expenses projected to fall by $66 million and no outages planned in the quarter.
$42 million remains on the $150 million share repurchase authorization from September 2023, and the board declared a $0.45 per share third quarter dividend.
Wendy's reported second-quarter 2025 results for the quarter ended June 29, 2025. Revenue and global systemwide sales declined, while diluted earnings per share rose 7.4% to $0.29, helped by a lower share count. The company lowered its full-year 2025 adjusted EPS and adjusted EBITDA outlook, which matters to shareholders because it signals weaker expected profit for the year.
Total revenues were $560.9 million, down 1.7% from $570.7 million a year earlier; diluted EPS was $0.29, up 7.4% from $0.27.
Global systemwide sales were $3.7 billion, down 1.8%; U.S. same-restaurant sales fell 3.6%, while International systemwide sales grew 8.7%.
Full-year adjusted EPS outlook is now $0.82 to $0.89, down from $0.92 to $0.98; adjusted EBITDA outlook is now $505 million to $525 million, down from $530 million to $545 million.
The board declared a regular quarterly dividend of $0.14 per share, payable September 16, 2025, to holders of record as of September 2, 2025.
Lamar Advertising reported second-quarter 2025 net revenues of $579.3 million, up 2.5%, and net income of $155.0 million, up 12.7%. The company lowered its full-year 2025 diluted AFFO per share guidance to $8.10 to $8.20 from $8.13 to $8.28, with CEO Sean Reilly citing expected revenue growth in the second half that may be smaller than anticipated at the start of the year.
Q2 2025 net revenues were $579.3 million versus $565.3 million in Q2 2024; diluted EPS was $1.52 versus $1.34
Full-year 2025 diluted AFFO per share guidance revised to $8.10 to $8.20 from $8.13 to $8.28
Q2 2025 cash flow from operations fell $26.9 million to $229.5 million; free cash flow was $199.1 million, down 2.2%
Total liquidity was $363.0 million as of June 30, 2025
ANI Pharmaceuticals reported second-quarter 2025 net revenues of $211.4 million, up 53.1% from a year earlier, and GAAP net income available to common shareholders of $8.1 million, or $0.36 per diluted share, compared with a loss of $0.14 per share in the prior-year period. The company raised its full-year 2025 guidance for net revenues to $818 million to $843 million and adjusted non-GAAP diluted EPS to $6.98 to $7.35.
Q2 2025 net revenues were $211.4 million, up 53.1% year over year, or 37.0% on an organic basis excluding the Alimera acquisition.
Cortrophin Gel net revenues were $81.6 million, up 66.0% year over year.
GAAP diluted EPS was $0.36 versus a loss of $0.14 a year earlier; adjusted non-GAAP diluted EPS was $1.80 versus $1.02.
Full-year 2025 net revenue guidance was raised to $818 million to $843 million from $768 million to $793 million.
Essent Group reported second-quarter 2025 net income of $195.3 million, or $1.93 per diluted share, versus $203.6 million, or $1.91 per diluted share, a year earlier, while total revenues rose to $319.1 million from $312.9 million. The company also declared a $0.31 quarterly dividend and disclosed $387 million of share repurchases year to date through July 31, which matters to shareholders because it returns capital while net income declined year over year.
Net income was $195.3 million for the quarter ended June 30, 2025, down from $203.6 million a year earlier; diluted EPS was $1.93 versus $1.91.
Total revenues were $319.1 million, up from $312.9 million in the second quarter of 2024.
Year to date through July 31, 2025, Essent repurchased 6.8 million shares for $387 million; $260 million remains under the $500 million plan.
The Board declared a $0.31 quarterly dividend, payable September 10, 2025, to holders of record on August 29, 2025.
Atmus Filtration Technologies reported second-quarter 2025 net sales of $454 million, up 4.8% from $433 million a year earlier, and GAAP net income of $60 million, or $0.72 per diluted share, versus $0.67 a year earlier. The company raised its 2025 outlook, with adjusted earnings per share now expected at $2.40 to $2.60, although gross margin fell to 28.9% from 30.5%.
Net sales of $454 million, up 4.8% from $433 million, driven mainly by higher volume and pricing
Diluted EPS of $0.72 versus $0.67; adjusted EPS of $0.75 versus $0.71
2025 guidance raised: revenue of $1,685 million to $1,735 million and adjusted EPS of $2.40 to $2.60
Gross margin 28.9% versus 30.5%; $20 million of stock repurchased during the quarter
ONEOK priced a $3.0 billion offering of senior notes in three tranches maturing in 2032, 2035 and 2055, with an expected net close of about $2.96 billion on or about August 12, 2025. The company plans to use the proceeds to repay all outstanding commercial paper and its senior notes due September 15, 2025, with any remaining funds for general corporate purposes, which may include debt repurchases or redemptions.
$750 million of 4.950% notes due 2032, $1.0 billion of 5.400% notes due 2035, and $1.25 billion of 6.250% notes due 2055
Expected net proceeds of about $2.96 billion, with closing expected on or about August 12, 2025
Proceeds to repay all outstanding commercial paper and senior notes due September 15, 2025, at maturity
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.